America January 30, 2026
AstraZeneca China Obesity Drug Deal Worth Up to $18.5B
Biotechnology powerhouse AstraZeneca has inked a landmark licensing agreement with China’s CSPC Pharmaceutical Group Ltd., potentially worth $18.5 billion, aimed…
America January 30, 2026
Biotechnology powerhouse AstraZeneca has inked a landmark licensing agreement with China’s CSPC Pharmaceutical Group Ltd., potentially worth $18.5 billion, aimed…
By Rihem Akkouche
Health October 19, 2024
In the United States, obesity is a major problem with longstanding ramifications. Recent CDC findings reveal that 40% of Americans…
By Gabrielle Seunagal
America June 4, 2024
The U.S. Supreme Court won’t hear Hi-Tech Pharmaceuticals’ challenge to the Federal Trade Commission’s $40 million judgment against it for…
By Rochdi Rais
Health February 27, 2024
In the United States, almost half of the population is obese. Some officials maintain that sedentary lifestyles and increased consumptions…
By Gabrielle Seunagal